# FDA Inspection 1022372 - MeriCal, LLC - June 13, 2017

Source: https://www.keypedia.com/records/fda_inspections/merical-llc/9c525fa5-17ca-48df-8b16-acb2c37fae19
Source feed: FDA_Inspections

> FDA Inspection 1022372 for MeriCal, LLC on June 13, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1022372
- Company Name: MeriCal, LLC
- Inspection Date: 2017-06-13
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1159237 - 2021-11-17](https://www.keypedia.com/records/fda_inspections/merical-llc/7ba6dda5-7e34-433e-b182-41e49a578c59)
- [FDA Inspection 911852 - 2015-01-23](https://www.keypedia.com/records/fda_inspections/merical-llc/f2e9bc07-d6ae-4742-aaad-2f306fa4765c)
- [FDA Inspection 705200 - 2011-01-04](https://www.keypedia.com/records/fda_inspections/merical-llc/55fa8cca-1995-46b9-9a60-cd10df88e3b3)
- [FDA Inspection 651028 - 2010-02-10](https://www.keypedia.com/records/fda_inspections/merical-llc/e51e5297-ad30-4ccb-a731-e80eadbd4f5e)

Company: https://www.keypedia.com/companies/merical-llc/d4a5dd92-4123-488e-8907-262b764b1d1e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
